Leflunomide: A new DMARD for rheumatoid arthritis

Hospital Medicine

Volumn 61, Issue 5, 2000, Pages 344-347

  Emery, Paul ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; IMMUNOLOGICAL ADJUVANT; ISOXAZOLE DERIVATIVE; LEFLUNOMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; RHEUMATOID ARTHRITIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED;

EID: 0034182871     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2000.61.5.1334     Document Type: Article

References (19)

1. Blower AL, Brooks A, Fenn GC, Hill A, Pearce MY, Morant S, Bardhau KD (1997) Emergency admissions for upper gastrointestinal disease and their relations to NSAID use. Aliment Pharmacol Ther 11: 283-91
2. Egsmose C, Lund B, Borg G, Pettersson H, Berg E, Brodin U, Trang L (1995) Patients with rheumatoid arthritis benefit from early second line therapy: five year follow-up of a prospective double blind placebo controlled study. J Rheumatol 22(12): 2208-13
3. Emery P, Zeidler H, Kvein TK et al (1999) Celecoxib vs diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet 354: 2106-11
4. Emery P, Breedveld SC, Lernmel EM et al (2000) A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology 39(6): (in press)
5. Fox RI (1998) Mechanism of action of leflunomide in rheumatoid arthritis. J Rheumalol 25 (Suppl 53): 20-26
6. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T (1989) Evidence of significant radiographie damage in rheumatoid arthritis within first two years of disease. J Rheumatol 16:585 91
7. Hosie G (1997) M IM S Guide to Primary Care Rheiimatolügv. Medical Imprint, London
8. Kalden JR. Schattenkirchner M, Smolen JS et al (1999) Leflunomide vs sulfasalazine in rheumatoid arthritis: 24 month update of a randomized, double-blind study. American College of Rheumatology 63rd National Scientific Meeting. Boston. Massachusetts. 12-17 November
9. McIntosh E ( 1996) The cost of rheumatoid arthritis. Br J Rheumatoid: 781-90
10. Mladenovic V, Domljan Z, Rozman B et al (1995) Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase 11 study. Arthritis Rheum 38: 1595-603
11. Monthly Index of Medical Specialties (2000) Monthly Index of Medical Specialties. Haymarket Medical Ltd, London
12. Moreland LW. Fleishmann RM for the Leflunomide RA Investigators Group. Strand V (1998) Efficacy of leflunomide vs placebo vs methotrexate in early and late rheumatoid arthritis. American College of Rheumatology 62nd National Scientific Meeting. San Diego, California, 8-12 November
13. Pincus T, Callahan LF, Sale WG, Brooks AL. Payne LE, Vaughn WK (1984) Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27:864-72
14. Scott DL, Schattenkirchner M, Smolen JR et al (1998) Efficacy of leflunomide v.v placebo vs sulfasalazine in rheumatoid arthritis: effect of disease duration. American College of Rheumatology 62nd National Scientific Meeting. San Diego. California. 8-12 November
15. Smolen JS, Kalden JR, Scott DL et al (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double blind randomised, multicentre trial. Lancet 353: 259-66
16. Smolen JS, Emery P (2000) Efficacy and safety of leflunomide in active rheumatoid arthritis. Rheumatology 39(suppl 1):43-51
17. Spector TD (1996) Epidemiology of rheumatic diseases. In: Snaith ML. ed. ABC of Rheumatology. BMJ Publishing Group, London: 82-5
18. Tugwell P, Bombadier C, Strand V et al (1998) Treatment of active rheumatoid arthritis with leflunomide improves functional activities and health related quality of life (HRQOL). American College of Rheumatology 62nd National Scientific Meeting, San Diego, California, 8-12 November
19. Weber W, Harnisch L (1998) Leflunomide in rheumatoid arthritis: population pharmacokinetic analysis of phase III studies. I 1th EULAR Congress, Geneva. 58 September